Amicogen Inc (092040)

Currency in KRW
4,045
-55(-1.34%)
Closed·
092040 Scorecard
Full Analysis
Stock generally trades with high price volatility
092040 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4,0404,185
52 wk Range
2,9005,440
Key Statistics
Bid/Ask
4,040.00 / 4,045.00
Prev. Close
4,045
Open
4,115
Day's Range
4,040-4,185
52 wk Range
2,900-5,440
Volume
198.06K
Average Volume (3m)
642.35K
1-Year Change
-12.63%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
092040 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Biotechnology industry

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Amicogen Inc Company Profile

Amicogen, Inc. operates as an industrial biotechnology company in South Korea and internationally. The company develops, produces, and sells of enzymes and new materials; and produces food-related additives and health functional food. It manufactures and sells of biopharmaceutical materials and resins for purifying pharmaceutical proteins and health and beauty products. In addition, the company offers oral incurable and rare disease treatments, as well as manufactures and sells of pharmaceutical raw materials, animal drugs, human drugs, etc. The company was incorporated in 2000 and is headquartered in Jinju-Si, South Korea.

Compare 092040 to Peers and Sector

Metrics to compare
092040
Peers
Sector
Relationship
P/E Ratio
−4.2x−10.2x−0.5x
PEG Ratio
0.11−0.120.00
Price/Book
1.9x2.7x2.6x
Price / LTM Sales
1.5x15.0x3.3x
Upside (Analyst Target)
-0.0%43.5%
Fair Value Upside
Unlock8.1%6.9%Unlock

Earnings

Latest Release
May 14, 2025
EPS / Forecast
-104.25 / --
Revenue / Forecast
10.82B / --
EPS Revisions
Last 90 days

092040 Income Statement

FAQ

What Stock Exchange Does Amicogen Trade On?

Amicogen is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Amicogen?

The stock symbol for Amicogen is "092040."

What Is the Amicogen Market Cap?

As of today, Amicogen market cap is 221.73B.

What Is Amicogen's Earnings Per Share (TTM)?

The Amicogen EPS (TTM) is -963.46.

From a Technical Analysis Perspective, Is 092040 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Amicogen Stock Split?

Amicogen has split 4 times.

How Many Employees Does Amicogen Have?

Amicogen has 225 employees.

What is the current trading status of Amicogen (092040)?

As of 07 Aug 2025, Amicogen (092040) is trading at a price of 4,045.00, with a previous close of 4,045.00. The stock has fluctuated within a day range of 4,040.00 to 4,185.00, while its 52-week range spans from 2,900.00 to 5,440.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.